Large-scale trials in intensive care

The economic value of large-scale clinical trials in intensive care – Steve Webb

Large-scale clinical trials are expensive and take years to go. Do they generate patient and economic benefit that justifies the cost of trials?

The Podcast

The Slides

The economic value of large-scale trials in intensive care from Coda Change

Steve splits his time between being an intensivist at Royal Perth Hospital and doing clinical trials. He is a former chair of the ANZICS CTG and has published more than 150 manuscripts including several major ANZICS trials. Steve has been involved in formation of the Australian Clinical Trials Alliance (ACTA), which represents trial networks across all disciplines, ACTA seeks better ways of doing trials to improve patient outcomes.